tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Neurosense Therapeutics Ltd

NRSN
Add to Watchlist
0.465USD
-0.011-2.27%
Close 07-31 16:00（ET）Quotes delayed by 15 min
15.15MMarket Cap
LossP/E TTM

Neurosense Therapeutics Ltd

0.465
-0.011-2.27%
Overview
Financials
Discussions
Analysis
Company

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-2.27%

5 Days

-22.74%

1 Month

-35.39%

6 Months

-49.43%

Year to Date

-39.51%

1 Year

-74.16%

Key Figures
0.480Open
0.500High
2.78MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
8.53%Turnover Ratio
0.476Prev. Close
0.432Low
760.68KTurnover
LossP/E Static
-9.71P/B
0.00%Div Yield TTM
-397.11%ROA
2.60052wk High
7.18Volume Ratio
-10.21MNet Profit
32.56MShares
-0.4366EPS TTM
1.57Beta
-2174.98%ROE
0.63052wk Low
14.22%Amplitude
--Gross Margin
15.15MMarket Cap
-5.65Reward/Risk
5.80%Risk Rate

Neurosense Therapeutics Ltd News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 3 analysts
Buy
Current Rating
6.500
Target Price
+1253.60%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Updated: Jul 31, 2026

Peer Comparison

496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Neurosense Therapeutics Ltd
NRSN
3
Beigene Ltd
ONC
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Updated: Jul 31, 2026

Indicators

Indicators
Sell(3)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.045
Sell
RSI(14)
16.473
Oversold
STOCH(KDJ)(9,3,3)
10.182
Oversold
ATR(14)
0.068
High Vlolatility
CCI(14)
-147.599
Sell
Williams %R
89.226
Oversold
TRIX(12,20)
-1.104
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
0.513
Sell
MA10
0.586
Sell
MA20
0.649
Sell
MA50
0.721
Sell
MA100
0.754
Sell
MA200
0.868
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Neurosense Therapeutics Ltd Info

NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Ticker SymbolNRSN
CompanyNeurosense Therapeutics Ltd
CEOBen-Noon (Alon)
Websitehttps://www.neurosense-tx.com/

Shareholders

Shareholders
Shareholders
Proportion
Ben-Noon (Alon)
11.82%
Rimon Gold Assets Ltd
9.34%
Eisenberg (Or)
3.55%
Tracik (Ferenc)
1.75%
Binder (Hagit)
1.44%
Other
72.11%

Related Instruments

LLY.NB
Eli Lilly and Co
-0.53%
JNJ.NB
Johnson & Johnson
+0.27%
AZN.NB
AstraZeneca PLC
-0.92%
ABBV.NB
AbbVie Inc
-2.51%
MRK.NB
Merck & Co Inc
+0.32%
NVS.NB
Novartis AG
-1.45%
AMGN.NB
Amgen Inc
-0.64%
GILD.NB
Gilead Sciences Inc
-0.82%
NVO.NB
Novo Nordisk A/S
-8.79%
PFE.NB
Pfizer Inc
+0.52%
BMY.NB
Bristol-Myers Squibb Co
+0.68%
VRTX.NB
Vertex Pharmaceuticals Inc
-0.95%
GSK.NB
GSK plc
-0.71%
SNY.NB
Sanofi SA
+0.44%
MCK.NB
Mckesson Corp
-1.08%
REGN.NB
Regeneron Pharmaceuticals Inc
+3.29%
VRNA.NB
0.00%
CAH.NB
Cardinal Health Inc
+1.30%
TAK.NB
Takeda Pharmaceutical Co Ltd
-0.90%
ARGX.NB
argenx SE
-2.15%

Popular Instruments

US30
52378.000
+109.000 (+0.21%)
NAS100
28160.900
-37.600 (-0.13%)
SPX500
7475.100
+30.800 (+0.41%)
CHINA 50
14749.000
-90.000 (-0.61%)
JPN225
62852.000
-742.000 (-1.17%)
EU50
6365.400
-1.000 (-0.02%)
WTI
85.934
+2.764 (+3.32%)
Apple Inc
308.910
-24.520 (-7.35%)
NVIDIA Corp
200.750
+5.710 (+2.93%)
Gold
4041.430
-61.400 (-1.50%)

FAQs

What is the current price of Neurosense Therapeutics Ltd (NRSN)?

The current price of Neurosense Therapeutics Ltd (NRSN) is 0.47.

What is the symbol of Neurosense Therapeutics Ltd?

The ticker symbol of Neurosense Therapeutics Ltd is NRSN.

What is the 52-week high of Neurosense Therapeutics Ltd?

The 52-week high of Neurosense Therapeutics Ltd is 2.60.

What is the 52-week low of Neurosense Therapeutics Ltd?

The 52-week low of Neurosense Therapeutics Ltd is 0.63.

What is the market capitalization of Neurosense Therapeutics Ltd?

The market capitalization of Neurosense Therapeutics Ltd is 15.24M.

Is Neurosense Therapeutics Ltd (NRSN) currently rated as Buy, Hold, or Sell?

According to analysts, Neurosense Therapeutics Ltd (NRSN) has an overall rating of Buy, with a price target of 6.50.

What is the Earnings Per Share (EPS TTM) of Neurosense Therapeutics Ltd (NRSN)?

The Earnings Per Share (EPS TTM) of Neurosense Therapeutics Ltd (NRSN) is -0.44.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy